<DOC>
	<DOCNO>NCT01797302</DOCNO>
	<brief_summary>In study , test central hypothesis enhancement vitamin D status obese overweight child improve vascular health cardiovascular disease ( CVD ) metabolic syndrome risk profile .</brief_summary>
	<brief_title>Vitamin D Vascular Health Children</brief_title>
	<detailed_description>Our primary objective determine , obese overweight child age 10 18 year vitamin D deficiency ( defined serum 25-hydroxyvitamin D &lt; 20 ng/mL ) , efficacy enhance vitamin D3 supplementation improve vascular endothelial function , arterial stiffness , insulin sensitivity , metabolic syndrome risk status ; ass whether effect dose-dependent . As secondary objective , examine vitamin D supplementation-induced effect adipokines inflammatory marker relevant CVD risk . In double-masked , controlled trial , randomize 252 eligible child receive either 600 IU ( conventional supplementation ) , 1000 IU 2000 IU ( enhanced supplementation ) vitamin D3 daily 6 month .</detailed_description>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Eligible subject 10 18 year age ; obese overweight ( BMI ≥85th % tile ) ; otherwise healthy , serum 25 ( OH ) D concentration &lt; 20 ng/mL Children take multivitamin able hold multivitamin course study . Children exclude ( ) hepatic renal disease , metabolic rickets , malabsorptive disorder , primary hyperparathyroidism , hyperthyroidism , chronic disorder could affect vitamin D metabolism ; ( b ) receive treatment anticonvulsant , systemic glucocorticoid , pharmacologic dos vitamin D ( ≥1000 IU vitamin D2 D3 daily ) , antihypertensives , vasoactive drug , antilipidemics , metformin , antipsychotic , oral insulin regulator ; ( c ) cholelithiasis urolithiasis ; ( ) type 1 type 2 diabetes ; ( e ) condition underlie abnormality could compromise safety subject . Postmenarchial girl positive pregnancy test randomization , subject find screen phase hypercalcemia ( serum calcium &gt; 10.8 mg/dL ) significant fast hyperglycemia ( fast blood glucose ≥ 125 mg/dL ) also exclude .</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Obesity</keyword>
	<keyword>Vitamin D Deficiency</keyword>
	<keyword>Vascular Function</keyword>
	<keyword>Insulin resistance</keyword>
	<keyword>metabolic syndrome</keyword>
</DOC>